Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
Guest Alerts | Access Rights | My Account | Sign In
|
|
Sci. STKE, 6 November 2001 PERSPECTIVESMelatonin Receptor Signaling: Finding the Path Through the DarkMonica I. Masana1 and Margarita L. Dubocovich2
1Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, IL 60611, USA. Summary: Melatonin, dubbed "the hormone of darkness," is involved in relaying photoperiodic information to the organism. Not only is melatonin involved in the regulation of circadian rhythms and sleep, but it also has roles in visual, cerebrovascular, reproductive, neuroendocrine, and neuroimmunological functions. Melatonin mediates its effects through G protein-coupled receptors: MT1, MT2, and, possibly, MT3. Pharmacological agents have been instrumental in identifying these receptor types. Masana and Dubocovich discuss how the level of receptor expression may alter their efficacy, so that caution is necessary when extrapolating the pharmacological properties of ligands defined on recombinant systems to the receptors in the organism. With these cautions in mind, they describe the various signaling pathways and physiological roles ascribed to the three melatonin receptor types. Corresponding author: Department of Molecular Pharmacology and Biological Chemistry (S-215), Northwestern University Medical School, 303 E. Chicago Avenue, Chicago, IL 60611, USA. Telephone: 312-503-8005, fax: 312-503-2334, e-mail: mdubo{at}northwestern.edu
Citation: M. I. Masana, M. L. Dubocovich, Melatonin Receptor Signaling: Finding the Path Through the Dark. Sci. STKE 2001, pe39 (2001). The editors suggest the following Related Resources on Science sites:In Science Signaling
|
Science Signaling. ISSN 1937-9145 (pre-2008: Science's STKE. ISSN 1525-8882)